Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem Treatment
NCT02506686 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 82
Last updated 2015-07-23
Summary
A prospective, open-label study investigated the pharmacokinetic profile of meropenem in patients with post-neurosurgical central nervous system (CNS) infection, especially its BBB penetration into cerebrospinal fluid (CSF).
Conditions
- Central Nervous System Infections
Interventions
- DRUG
-
Meropenem i.v.
Sponsors & Collaborators
-
Huashan Hospital
lead OTHER
Principal Investigators
-
Jufang Wu, MD · Huashan Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
More Related Trials
-
Etiology of Orphan Community-based Meningitis and Meningo-encephalitis.
NCT02868593 ·Status: UNKNOWN ·Phase: NA
-
Rapid Test for Detection of the Focus of Infection in Post Neurosurgical Patients.
NCT03252028 ·Status: UNKNOWN
-
Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy
NCT02129465 ·Status: UNKNOWN
-
Serology to COVID-19 for Recording Exposures and Evaluating Needs
NCT04566965 ·Status: TERMINATED
-
Assessment of sTREM-1 as a Diagnostic Marker in Patients With Neutropenic Fever
NCT01034059 ·Status: COMPLETED
-
Maternal- Fetal Infection
NCT03371056 ·Status: COMPLETED ·Phase: NA
-
Azithromycin for Preventing Maternal and Neonatal Infections During Labor.
NCT06958146 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Pediatric Infectious Disease Precision Medicine Using Sequencing Evaluation of CSF
NCT03796546 ·Status: COMPLETED
-
Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis
NCT06921213 ·Status: RECRUITING ·Phase: PHASE2
-
Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
NCT02527681 ·Status: TERMINATED ·Phase: PHASE1
-
COVID-19 and Obstetric Transmission
NCT04418557 ·Status: COMPLETED
-
Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
NCT05315583 ·Status: TERMINATED ·Phase: NA
-
Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae
NCT02961751 ·Status: COMPLETED ·Phase: NA
-
Treatment Utility of Postpartum Antibiotics in Chorioamnionitis
NCT01585129 ·Status: TERMINATED ·Phase: PHASE4
-
COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur
NCT04369066 ·Status: COMPLETED ·Phase: NA
-
Restoration of Antibiotics Related Infant Microbiota Perturbations by Autologous Fecal Transplant
NCT06609980 ·Status: RECRUITING ·Phase: PHASE1
-
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
NCT01251744 ·Status: COMPLETED ·Phase: NA
-
Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries
NCT03248297 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
NCT00699868 ·Status: COMPLETED ·Phase: NA
-
Clinical Value of Metagenomic Sequencing in Neonatal Sepsis
NCT05416918 ·Status: COMPLETED
-
Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia
NCT00913042 ·Status: COMPLETED
-
Procalcitonin Levels in Patients With Fever and a Central Line
NCT01175005 ·Status: COMPLETED
-
Cologne Cohort of Neutropenic Patients (CoCoNut)
NCT01821456 ·Status: RECRUITING
-
Molecular Culture for the Diagnosis of Neonatal Sepsis
NCT05763680 ·Status: UNKNOWN
-
Evaluation of the Levels of Calcitonin Gene-related Peptide and Substance P
NCT06510751 ·Status: RECRUITING